Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Harder

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Leukemia|October 3, 2003
Segmental chromosomal aberrations and centrosome amplifications: pathogenetic mechanisms in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma?J I Martín-Subero, U Knippschild, L Harder, et al.
Blood|November 11, 1999
Clinicopathogenetic significance of chromosomal abnormalities in patients with blastic peripheral B-cell lymphoma. Kiel-Wien-Lymphoma Study GroupB Schlegelberger, T Zwingers, L Harder, et al.
Scientific Reports|September 15, 2019
Suitability of ultrasound-guided fine-needle aspiration biopsy for transcriptome sequencing of the canine prostateH Thiemeyer, L Taher, J T Schille, et al.
Journal of the American Society of Nephrology : JASN|June 2, 2019
Changes in Albuminuria But Not GFR are Associated with Early Changes in Kidney Structure in Type 2 DiabetesHelen C Looker, Michael Mauer, Pierre-Jean Saulnier, et al.
Onkologie|July 7, 2001
Treatment of aggressive, or progressing indolent peripheral T- and NK-cell neoplasias by combination of fludarabine, cyclophosphamide and doxorubicineE Weidmann, S Boehrer, K U Chow, et al.
American Journal of Hematology|January 5, 2002
Cytogenetic and molecular characterization of a patient with simultaneous B-cell chronic lymphocytic leukemia and peripheral T-cell lymphomaJ I Martin-Subero, R Siebert, L Harder, et al.
Molecular and Cellular Biology|October 30, 2013
Crumbs3 is essential for proper epithelial development and viabilityEileen L Whiteman, Shuling Fan, Jennifer L Harder, et al.
Blood|October 25, 2001
Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignanciesT Sonoki, L Harder, D E Horsman, et al.
Kidney International|October 22, 2017
A molecular morphometric approach to diabetic kidney disease can link structure to function and outcomeViji Nair, Claudiu V Komorowsky, E Jennifer Weil, et al.
Blood|November 24, 2001
The BCL11 gene family: involvement of BCL11A in lymphoid malignanciesE Satterwhite, T Sonoki, T G Willis, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Leukemia|October 3, 2003
Segmental chromosomal aberrations and centrosome amplifications: pathogenetic mechanisms in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma?J I Martín-Subero, U Knippschild, L Harder, et al.
Blood|November 11, 1999
Clinicopathogenetic significance of chromosomal abnormalities in patients with blastic peripheral B-cell lymphoma. Kiel-Wien-Lymphoma Study GroupB Schlegelberger, T Zwingers, L Harder, et al.
Scientific Reports|September 15, 2019
Suitability of ultrasound-guided fine-needle aspiration biopsy for transcriptome sequencing of the canine prostateH Thiemeyer, L Taher, J T Schille, et al.
Journal of the American Society of Nephrology : JASN|June 2, 2019
Changes in Albuminuria But Not GFR are Associated with Early Changes in Kidney Structure in Type 2 DiabetesHelen C Looker, Michael Mauer, Pierre-Jean Saulnier, et al.
Onkologie|July 7, 2001
Treatment of aggressive, or progressing indolent peripheral T- and NK-cell neoplasias by combination of fludarabine, cyclophosphamide and doxorubicineE Weidmann, S Boehrer, K U Chow, et al.
American Journal of Hematology|January 5, 2002
Cytogenetic and molecular characterization of a patient with simultaneous B-cell chronic lymphocytic leukemia and peripheral T-cell lymphomaJ I Martin-Subero, R Siebert, L Harder, et al.
Molecular and Cellular Biology|October 30, 2013
Crumbs3 is essential for proper epithelial development and viabilityEileen L Whiteman, Shuling Fan, Jennifer L Harder, et al.
Blood|October 25, 2001
Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignanciesT Sonoki, L Harder, D E Horsman, et al.
Kidney International|October 22, 2017
A molecular morphometric approach to diabetic kidney disease can link structure to function and outcomeViji Nair, Claudiu V Komorowsky, E Jennifer Weil, et al.
Blood|November 24, 2001
The BCL11 gene family: involvement of BCL11A in lymphoid malignanciesE Satterwhite, T Sonoki, T G Willis, et al.
Pageof 9